DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Return
2.74%
This Quarter Return
+5%
1 Year Return
-2.74%
3 Year Return
+59.83%
5 Year Return
+118.92%
10 Year Return
–
AUM
$348M
AUM Growth
+$2.22M
(+0.64%)
Cap. Flow
-$8.91M
Cap. Flow
% of AUM
-2.56%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
199
New
16
Increased
16
Reduced
87
Closed
12
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$6.23M |
| 2 |
Cintas
CTAS
|
$5.57M |
| 3 |
Oshkosh
OSK
|
$5.5M |
| 4 |
HealthEquity
HQY
|
$5.07M |
| 5 |
Teradyne
TER
|
$4.98M |
Top Sells
| 1 |
PetMed Express
PETS
|
$10.8M |
| 2 |
Lam Research
LRCX
|
$6.62M |
| 3 |
Danaher
DHR
|
$5.11M |
| 4 |
Eagle Materials
EXP
|
$5.1M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
$4.41M |
Sector Composition
| 1 | Healthcare | 18.88% |
| 2 | Industrials | 14.93% |
| 3 | Technology | 14.51% |
| 4 | Financials | 13.13% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
HealthEquity
HQY
$8.42B
| $5.07M | 1.46% |
+100,260
| New | +$5.07M |
|
|
27
Teradyne
TER
$19B
| $4.98M | 1.43% |
+133,401
| New | +$4.98M |
|
28
Dycom Industries
DY
$7.35B
| $4.8M | 1.38% |
55,910
-2,015
| -3% | -$173K |
|
29
Pfizer
PFE
$140B
| $4.59M | 1.32% |
135,588
-3,372
| -2% | -$114K |
|
30
Bristol-Myers Squibb
BMY
$95B
| $3.89M | 1.12% |
61,022
-1,324
| -2% | -$84.4K |
|
31
Norfolk Southern
NSC
$62.8B
| $3.68M | 1.06% |
27,844
-646
| -2% | -$85.4K |
|
32
Consolidated Edison
ED
$35.3B
| $3.67M | 1.05% |
45,464
-1,250
| -3% | -$101K |
|
33
Vanguard FTSE Emerging Markets ETF
VWO
$96.1B
| $3.33M | 0.95% |
76,337
-3,184
| -4% | -$139K |
|
34
PepsiCo
PEP
$201B
| $3.11M | 0.89% |
27,923
-800
| -3% | -$89.1K |
|
35
Southern Company
SO
$101B
| $3.01M | 0.87% |
61,323
-1,620
| -3% | -$79.6K |
|
36
Dominion Energy
D
$50.2B
| $2.96M | 0.85% |
38,426
-25
| -0.1% | -$1.92K |
|
37
Truist Financial
TFC
$60.7B
| $2.84M | 0.81% |
60,406
-735
| -1% | -$34.5K |
|
38
Nuveen Preferred & Income Opportunities Fund
JPC
$2.62B
| $2.8M | 0.8% |
264,650
-10,100
| -4% | -$107K |
|
39
ICU Medical
ICUI
$3.1B
| $2.79M | 0.8% |
14,995
+75
| +0.5% | +$13.9K |
|
40
AT&T
T
$212B
| $2.67M | 0.77% |
90,389
-4,535
| -5% | -$134K |
|
41
Intel
INTC
$108B
| $2.67M | 0.77% |
69,993
-170
| -0.2% | -$6.47K |
|
|
AGN
42
DELISTED
Allergan plc
AGN
| $2.64M | 0.76% |
12,870
-440
| -3% | -$90.2K |
|
43
International Paper
IP
$25.5B
| $2.51M | 0.72% |
46,555
+629
| +1% | +$33.8K |
|
44
DuPont de Nemours
DD
$32.3B
| $2.41M | 0.69% |
17,268
+14,564
| +539% | +$2.03M |
|
45
Vanguard Real Estate ETF
VNQ
$34.3B
| $2.37M | 0.68% |
28,505
-655
| -2% | -$54.4K |
|
46
Eli Lilly
LLY
$666B
| $2.36M | 0.68% |
27,540
-1,050
| -4% | -$89.8K |
|
47
Verizon
VZ
$186B
| $2.29M | 0.66% |
46,217
-3,298
| -7% | -$163K |
|
48
Travelers Companies
TRV
$62.9B
| $2.24M | 0.64% |
18,256
-1,000
| -5% | -$123K |
|
49
Cisco
CSCO
$269B
| $2.2M | 0.63% |
65,499
-2,074
| -3% | -$69.8K |
|
50
Chevron
CVX
$318B
| $2.12M | 0.61% |
18,040
+320
| +2% | +$37.6K |
|